COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,169 Articles (22,703 medRxiv, 8,466 bioRxiv)

Most recent first Previous |  Page 538: Articles 5371-5380  | Next

BCG vaccination of healthcare workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomised placebo-controlled trial
Claus, J., ten Doesschate, T., Gumbs, C., van Werkhoven, C. H., van der Vaart, T. W., Janssen, A. B., Smits, G., van Binnendijk, R., van der Klis, F., van Baarle, D., Paganelli, F. L., Leavis, H., Verhagen, L. M., Joosten, S. A., Bonten, M. J. M., Netea, M. G., van de Wijgert, J. H.
10.1101/2022.12.12.22283282 — Posted: 2022-12-13
The COVID-19 pandemic and its prolonged impacts on food prices, food consumption and diet quality in sub-Saharan Africa
Madzorera, I., Ismail, A., Apraku, E. A., Tinkasimile, A., Dasmane, D., Zabre, P., Ourohire, M., Assefa, N., Chukwu, A., Workneh, F., Mapendo, F., Lankoande, B., Hemler, E., Wang, D., Abubakari, S. W., Asante, K. P., Baernighausen, T., Killewo, J., Oduola, A., Sie, A., Soura, A., Vuai, S., Smith, E., Berhane, Y., Fawzi, W. W.
10.1101/2022.12.12.22283393 — Posted: 2022-12-13
Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
Liu, X., Park, H.-S., Matsuoka, Y., Santos, C., Yang, L., Luongo, C., Moore, I., Johnson, R., Garza, N., Zhang, P., Lusso, P., Best, S., Buchholz, U., Le Nouën, C.
10.1101/2022.12.12.520032 — Posted: 2022-12-13
Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants
Wu, J., Chen, Z., Gao, Y., Wang, Z., Wang, J., Chiang, B.-Y., Zhou, Y., Han, Y., Zhan, W., Xie, M., Jiang, W., Zhang, X., Hao, A., Xia, A., He, J., Xue, S., Mayer, C. T., Wu, F., Wang, B., Zhang, L., Sun, L., Wang, Q.
10.1101/2022.12.12.520172 — Posted: 2022-12-13
Stress, Genetics and Mood: Impact of COVID-19 on a College Freshman Sample
Turner, C. A., Khalil, H., Murphy-Weinberg, V., Hagenauer, M. H., Gates, L., Tang, Y., Weinberg, L., Grysko, R., Floran-Garduno, L., Dokas, T., Zhao, Z., Fang, Y., Sen, S., Lopez, J. F., Watson, S. J., Akil, H.
10.1101/2022.12.13.22283409 — Posted: 2022-12-13
Healthcare Facility Water, Sanitation and Hygiene Service Status and Barriers in Ethiopia: Its Implication for COVID-19 pandemic and Healthcare Acquired Infection Prevention.
Derso, A., Addis, T., Mengistie, B., Keleb, A., Adedmas, A.
10.1101/2022.12.09.22283296 — Posted: 2022-12-13
COVID-19 Reinfections in Mexico City: Implications for public health response
de Anda-Jauregui, G., Gomez-Romero, L., Cedro-Tanda, A., Canas, S., Campos-Romero, A., Alcantar-Fernandez, J., Hidalgo-Miranda, A., Herrera-Montalvo, L. A.
10.1101/2022.12.08.22283269 — Posted: 2022-12-13
Safety and Immunogenicity of an Omicron BA.4/BA.5 Bivalent Vaccine against Covid-19
Chalkias, S., Whatley, J., Eder, F., Essink, B., Khetan, S., Bradley, P., Brosz, A., McGhee, N., Tomassini, J. E., Chen, X., Sutherland, A., Shen, X., Girard, B., Edwards, D. K., Feng, J., Zhou, H., Walsh, S. R., Montefiori, D. C., Baden, L. R., Miller, J. M., Das, R.
10.1101/2022.12.11.22283166 — Posted: 2022-12-13
The Use and Safety Risk of Repurposed Drugs for COVID-19 patients: Lessons Learned Utilizing the Food and Drug Administrations Adverse Event Reporting System
Alsuhaibani, D. S., Edrees, H. H., Alshammari, T. M.
10.1101/2022.12.10.22283298 — Posted: 2022-12-13
Reduced mortality among COVID-19 ICU patients after treatment with HemoClear convalescent plasma in Suriname
Bihariesingh-Sanchit, R., Bansie, R., Ramdhani, N., Mangroo, R., Bustamente, D., Diaz, E., Fung A Foek, C., Thakoer, I., Vreden, S. C., Choudry, Z., van 't Wout, A. B., Diavatopoulos, D. A., Nierich, A. P.
10.1101/2022.12.10.22283287 — Posted: 2022-12-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).